Kiniksa Pharmaceuticals International, plc (KNSA)
Market Closed
1 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
79. 28
+0.65
+0.8267%
After Hours
$
+0.01 +0.0126% 79. 29
5.99B Market Cap
84.4 P/E Ratio
- Div Yield
386,944 Volume
-0.16 Eps
$ 78.63
Previous Close 
Want to track KNSA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Kiniksa Pharmaceuticals International, plc (KNSA) Statistics
Valuation metrics
Market Cap 5.99B
Enterprise value 5.78B
Trailing P/E (ttm) 72.97
Forward P/E -
PEG ratio 0.04
Price/Sales (ttm) 7.08
Price/Book (mrq) 9.26
Enterprise Value/Revenue 6.88
Enterprise Value/EBITDA 51.59
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 427.25K
Average volume (90 days) 1.12M
Price summary
52-Week low 33.45
52-Week high 82.94
Beta -
50-Day moving average 77.93
200-Day moving average 51.09
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.1%
Operating margin 0.12%
Operational effectiveness
Return on assets 0.09%
Return on equity 0.14%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 10.84
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 1.04
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 6.78
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 3.9%
Book value per share (mrq) 8.43
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
